BioVision announces the winners of the 2011 BioVision-Lilly Award, in conjunction with TWAS
The 2011 Award recognized 4 young scientists, living and working in developing countries, who have a track record of excellent research in the field of tuberculosis, and whose work promises to have a positive impact in the developing world.
The awards and certificates were presented by Mr. Bart Peterson, Senior Vice-President, Corporate Affairs and Communication, Eli Lilly and Company; and, representing TWAS and BioVision, Mr. Christian Grenier, CEO, BioVision.
“We have been impressed with the quality of the competition and especially the winners,” says Bart Peterson. “TB largely afflicts the developing world and I’m heartened to see that young developingworld scientists are taking their position at the forefront of global research being carried out into this debilitating disease.”
The winners were selected from among 40 entries by an international jury of world-class academics, chaired by Jacob Palis, President of TWAS, and Professor at the Instituto Nacional de Matemática Pura e Aplicada in Rio de Janeiro, Brazil. The first- and second-place winners received funding to continue their research.
Dr. Digby Warner, Sr. Research Officer, MRC/NHLS/UCT Molecular Mycobacteriology Research Unit, University of Cape Town, South Africa – Winner of the 2011 BioVision Lilly Award, in conjunction with TWAS: Warner is honoured for his work on mycobacterial metabolism which promises to have a major impact on understanding the development of drug-resistance in Mycobacterium tuberculosis.
Dr. Thomas Scriba, Senior Researcher, South African TB Vaccine Initiative, University of Cape Town – First runner-up: Scriba is honoured for his work on TB vaccines.
Dr. Dihandenys Lemus, Tuberculosis National Reference Laboratory in Havana, Cuba and Prof. Joy Sarojini Michael, Christian Medical College of Vellore, India – Joint third. Dihandenys Lemus is honoured for her work in drug-resistant tuberculosis and Joy Sarojini Michael for her research in new TB diagnostics.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.